NCT04450472 is a clinical trial in Nonthyroidal Illness Syndrome, sponsored by Jinling Hospital, China.

Who is sponsoring NCT04450472?

NCT04450472 is sponsored by Jinling Hospital, China.

What condition does NCT04450472 study?

NCT04450472 studies Nonthyroidal Illness Syndrome, Short Bowel Syndrome.

Is NCT04450472 still recruiting?

NCT04450472 is currently completed. Last updated 29 June 2020.

Last reviewed 2020-06-29 · How we verify

NCT04450472

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nonthyroidal Illness Syndrome in SBS

Completed Last updated 29 June 2020

What this trial tests

trial in Nonthyroidal Illness Syndrome in 51 participants. Completed in 31 December 2018.

Timeline

31 December 2016

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Jinling Hospital, China
Status	Completed
Study type	OBSERVATIONAL
Enrollment	51
Start date	31 December 2016
Primary completion	31 December 2018
Estimated completion	31 December 2018

Conditions studied

Nonthyroidal Illness Syndrome — all drugs for Nonthyroidal Illness Syndrome →
Short Bowel Syndrome — all drugs for Short Bowel Syndrome →

Sponsor

Jinling Hospital, China

Who can join

18 and older, any sex, with Nonthyroidal Illness Syndrome or Short Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nonthyroidal illness syndrome (NTIS) is prevalent in critical illness; it is associated with poor outcomes. However, few studies have focused on the relationship between NTIS and short bowel syndrome (SBS). The aim of this study was to investigate the incidence, etiology, and prognosis of NTIS and its correlation in clinical variables in adult patients with SBS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Jinling Hospital, China trials

Trials by the same sponsor.

NCT07297238 — Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration. · NA · recruiting
NCT07237542 — Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction · NA · recruiting
NCT07230314 — Sequential Transarterial Chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), and Immune Checkpoint Inh · Phase 2 · not yet recruiting
NCT06177522 — Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer · Phase 2 · not yet recruiting
NCT07124624 — Stepped-Wedge Cluster Randomized Trial of AI-Assisted CTA Detection for Intracranial Aneurysms in Regional Hospitals · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04450472 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jinling Hospital, China
Last refreshed: 29 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04450472.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing